Intravenous posaconazole: key features of clinical pharmacology and practical applications
Invasive fungal infections in various categories of patients remain one of the most urgent problems of modern medicine. This is complicated by the imperfection of diagnostic methods, as well as a small range of antimycotics for systemic use. The market launch in 2005 of posaconazole, a second-genera...
Saved in:
| Main Authors: | A. V. Veselov, N. N. Klimko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-04-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/544 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative pharmacoeconomic analysis of posaconazole therapy in tablet form and in suspension for invasive fungal infections prevention
by: I. S. Krysanov, et al.
Published: (2021-06-01) -
Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia
by: Anna Sophia Gottschlich, et al.
Published: (2025-08-01) -
Updating information of mycoses and antifungal medicines to find effective platforms for the production of new thiazole compounds
by: T. F. Chernykh, et al.
Published: (2024-11-01) -
Posaconazole loaded bilosomes as a novel vesicular carrier for topical treatment of fungal infections: Formulation, optimization, ex-vivo permeation and antifungal assay
by: Shital Bahadure, et al.
Published: (2025-01-01) -
Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review
by: Ruochen Qu, et al.
Published: (2024-12-01)